The global thrombosis and hemostasis biomarkers market size is expected to reach USD 7.92 Billion by 2030, expanding at a CAGR of 5.90% from 2023 to 2030, according to this report. The rapid growth of the market is attributable to factors such as the increasing prevalence of chronic diseases such as pancreatic cancer, the rise in the geriatric population, the growing demand for personalized medicines, and advancements in technology. ![Global Thrombosis and Hemostasis Biomarkers Market]( "Global Thrombosis and Hemostasis Biomarkers Market")
The thrombosis & hemostasis biomarkers industry has grown significantly in recent years, with changes in adoption patterns and the introduction of novel technologies. The increasing trend of adopting POC analyzers in the market is creating traction for small-sized analyzers. Increasing research on mini- and microdevices is anticipated to continue over the coming years. For instance, in June 2022, Dr. Arnold Lining Ju announced the development of a microdevice that can detect blood clots and can be used to detect early signs of a heart attack.
The prevalence of chronic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and pancreatic cancer is anticipated drive the need for thrombosis & hemostasis biomarkers to detect the probability of hemostasis. Chronic diseases have a tendency to damage blood vessels, leading to the formation of clots that can block blood flow and cause serious health complications, such as stroke & heart attack. For instance, pulmonary embolism (PE), is a serious medical condition that occurs in the legs and travels to the lung, obstructing blood flow.
As per American Lung Association, in January 2023, PE affected nearly 900,000 people in the U.S. and nearly 33% of the people affected by (DVT) or pulmonary embolism (PE) experience recurrence of PE in ten years. Therefore, high prevalence and significant repetition of cases will lead to an increase in the demand for thrombosis & hemostasis biomarkers.
Furthermore, key players operating in the market are focusing on different forms of strategic initiatives such as mergers and acquisitions to increase their respective position in the thrombosis & hemostasis biomarkers industry. For instance, in January 2023, Thermo Fisher Scientific, Inc., announced a partnership with AstraZeneca to manufacture a blood-based and solid tissue companion diagnostic test for Tagrisso. This was expected to propel the thrombosis and hemostasis biomarkers industry. Additionally, in May 2022, Quidel Corporation acquired Ortho Clinical Diagnostics for USD 6 billion. The new company was named QuidelOrtho. Through this acquisition, Quidel gained access to Ortho Clinical Diagnostics’ biomarker tests portfolio.
The thrombosis & hemostasis biomarkers industry has grown significantly in recent years, with changes in adoption patterns and the introduction of novel technologies. The increasing trend of adopting POC analyzers in the market is creating traction for small-sized analyzers. Increasing research on mini- and microdevices is anticipated to continue over the coming years. For instance, in June 2022, Dr. Arnold Lining Ju announced the development of a microdevice that can detect blood clots and can be used to detect early signs of a heart attack.
The prevalence of chronic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and pancreatic cancer is anticipated drive the need for thrombosis & hemostasis biomarkers to detect the probability of hemostasis. Chronic diseases have a tendency to damage blood vessels, leading to the formation of clots that can block blood flow and cause serious health complications, such as stroke & heart attack. For instance, pulmonary embolism (PE), is a serious medical condition that occurs in the legs and travels to the lung, obstructing blood flow.
As per American Lung Association, in January 2023, PE affected nearly 900,000 people in the U.S. and nearly 33% of the people affected by (DVT) or pulmonary embolism (PE) experience recurrence of PE in ten years. Therefore, high prevalence and significant repetition of cases will lead to an increase in the demand for thrombosis & hemostasis biomarkers.
Furthermore, key players operating in the market are focusing on different forms of strategic initiatives such as mergers and acquisitions to increase their respective position in the thrombosis & hemostasis biomarkers industry. For instance, in January 2023, Thermo Fisher Scientific, Inc., announced a partnership with AstraZeneca to manufacture a blood-based and solid tissue companion diagnostic test for Tagrisso. This was expected to propel the thrombosis and hemostasis biomarkers industry. Additionally, in May 2022, Quidel Corporation acquired Ortho Clinical Diagnostics for USD 6 billion. The new company was named QuidelOrtho. Through this acquisition, Quidel gained access to Ortho Clinical Diagnostics’ biomarker tests portfolio.
Thrombosis And Hemostasis Biomarkers Market Report Highlights
- Reagents and consumables segment of the market held the largest revenue share in 2022 and is attributable to the heightened prevalence of bleeding and coagulation disorders in the global population
- Clinical laboratory tests led the overall market in 2022, owing to their ability to diagnose and identify abnormalities in the blood clotting process while processing a high volume of samples
- Post-thrombin (PT) test held the largest revenue share in 2022, attributable to the test quality which allows monitoring the effectiveness of anticoagulant medications
- Deep Vein Thrombosis (DVT) held the largest revenue share in 2022, owing to its high prevalence and the high mortality risk
- Diagnostic centers held the largest revenue share in 2022, attributable to the growing reliance of hospitals on diagnostic centers for testing and the presence of specialized equipment to provide faster test results
- North America dominated the market in 2022 which can be attributed to a significant prevalence of thrombosis and hemostasis disorders, along with access to advanced technology
- A few of the key market playersinclude bioMérieux SA; Abbott; Werfen; HORIBA Ltd.; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Diazyme Laboratories, Inc.; Biomedica Diagnostics; Thermo Fisher Scientific, Inc.; Siemens Healthineers.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Test Location Segment
1.1.1.3 Test Type Segment
1.1.1.4 Application Segment
1.1.1.5 End-Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Test Location Segment
1.1.1.3 Test Type Segment
1.1.1.4 Application Segment
1.1.1.5 End-Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product And Test Location Segment Snapshot
2.3 Test Type Segment Snapshot
2.4 Application And End Use Segment Snapshot
2.5 Competitive Landscape Snapshot
2.2 Product And Test Location Segment Snapshot
2.3 Test Type Segment Snapshot
2.4 Application And End Use Segment Snapshot
2.5 Competitive Landscape Snapshot
Chapter 3 Thrombosis & Hemostasis Biomarkers Market Variables, Trends, And Scope
3.1 Thrombosis & Hemostasis Biomarkers Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Prevalence Of Chronic Diseases
3.2.1.1.1 Incidence Data Of Pancreatic Cancer
3.2.1.2 Growing Geriatric Population
3.2.1.3 Increasing Demand For Personalized Medicine
3.2.1.4 Advancements In Technology
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Diagnostic Tests
3.2.2.2 Complexity Of Thrombotic Events
3.3 Thrombosis & Hemostasis Biomarkers Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestle Analysis
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Prevalence Of Chronic Diseases
3.2.1.1.1 Incidence Data Of Pancreatic Cancer
3.2.1.2 Growing Geriatric Population
3.2.1.3 Increasing Demand For Personalized Medicine
3.2.1.4 Advancements In Technology
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Diagnostic Tests
3.2.2.2 Complexity Of Thrombotic Events
3.3 Thrombosis & Hemostasis Biomarkers Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestle Analysis
Chapter 4 Thrombosis & Hemostasis Biomarkers Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Thrombosis & Hemostasis Biomarkers Market: Product Movement Analysis
4.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Product (USD Million)
4.2.1 Analyzers
4.2.2 Reagents & Consumables
4.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Product (USD Million)
4.2.1 Analyzers
4.2.2 Reagents & Consumables
Chapter 5 Thrombosis & Hemostasis Biomarkers Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)
5.1 Thrombosis & Hemostasis Biomarkers Market: Test Location Movement Analysis
5.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Test Location (USD Million)
5.2.1 Clinical Laboratory Tests
5.2.2 Point-Of-Care Tests
5.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Test Location (USD Million)
5.2.1 Clinical Laboratory Tests
5.2.2 Point-Of-Care Tests
Chapter 6 Thrombosis & Hemostasis Biomarkers Market - Segment Analysis, By Test Type, 2018 - 2030 (USD Million)
6.1 Thrombosis & Hemostasis Biomarkers Market: Test Type Movement Analysis
6.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Test Type (USD Million)
6.2.1 D-Dimer
6.2.2 Anti-Thrombin Iii
6.2.3 Plasminogen
6.2.4 Fibrin/Fibrinogen
6.2.5 Soluble Fibrin
6.2.6 Selectins
6.2.7 Factor Viii
6.2.8 Pt
6.2.9 Aptt
6.2.10 Others
6.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Test Type (USD Million)
6.2.1 D-Dimer
6.2.2 Anti-Thrombin Iii
6.2.3 Plasminogen
6.2.4 Fibrin/Fibrinogen
6.2.5 Soluble Fibrin
6.2.6 Selectins
6.2.7 Factor Viii
6.2.8 Pt
6.2.9 Aptt
6.2.10 Others
Chapter 7 Thrombosis & Hemostasis Biomarkers Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
7.1 Thrombosis & Hemostasis Biomarkers Market: Application Movement Analysis
7.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Application (USD Million)
7.2.1 Deep Vein Thrombosis (Dvt)
7.2.2 Pulmonary Embolism (Pe)
7.2.3 Disseminated Intravascular Coagulation (Dic)
7.2.4 Others
7.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By Application (USD Million)
7.2.1 Deep Vein Thrombosis (Dvt)
7.2.2 Pulmonary Embolism (Pe)
7.2.3 Disseminated Intravascular Coagulation (Dic)
7.2.4 Others
Chapter 8 Thrombosis & Hemostasis Biomarkers Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)
8.1 Thrombosis & Hemostasis Biomarkers Market: End-Use Movement Analysis
8.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By End Use (USD Million)
8.2.1 Hospitals & Clinics
8.2.2 Academic & Research Institute
8.2.3 Diagnostic Centers
8.2.4 Others
8.2 Thrombosis & Hemostasis Biomarkers Market Estimates & Forecast, By End Use (USD Million)
8.2.1 Hospitals & Clinics
8.2.2 Academic & Research Institute
8.2.3 Diagnostic Centers
8.2.4 Others
Chapter 9 Thrombosis & Hemostasis Biomarkers Market: Regional Estimates And Trend Analysis, By Product, Test Location, Test Type, Application, & End-Use
9.1 Thrombosis & Hemostasis Market: Regional Outlook
9.2 North America
9.2.1 North America Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 U.S. Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2.4 Competitive Scenario
9.2.2.5 Regulatory Framework
9.2.2.6 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Canada Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2 Uk
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 Uk Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Germany Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 France Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Spain
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Spain Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Italy
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Italy Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Denmark Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.7.4 Competitive Scenario
9.3.7.5 Regulatory Framework
9.3.7.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Target Disease Prevalence
9.3.8.3 Sweden Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Target Disease Prevalence
9.3.9.3 Norway Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.10 Rest Of Europe
9.4 Asia Pacific
9.4.1 Asia Pacific Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Death Rate In Japan
9.4.2.3 Target Disease Prevalence
9.4.2.4 Japan Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2.5 Competitive Scenario
9.4.2.6 Regulatory Framework
9.4.2.7 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 China Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 India Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4.4 Competitive Scenario’
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 South Korea
9.4.5.1 Key Country Dynamics
9.4.5.2 Target Disease Prevalence
9.4.5.3 South Korea Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 Australia
9.4.6.1 Key Country Dynamics
9.4.6.2 Target Disease Prevalence
9.4.6.3 Australia Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Target Disease Prevalence
9.4.7.3 Thailand Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.7.4 Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.4.8 Rest Of Asia Pacific
9.5 Latin America
9.5.1 Latin America Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Mexico Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Argentina Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.5 Rest Of Latin America
9.6 MEA
9.6.1 MEA Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 Target Disease Prevalence
9.6.2.3 South Africa Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Target Disease Prevalence
9.6.3.3 Saudi Arabia Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 Target Disease Prevalence
9.6.4.3 Uae Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Target Disease Prevalence
9.6.5.3 Kuwait Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
9.6.6 Rest Of Mea
9.2 North America
9.2.1 North America Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 U.S. Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2.4 Competitive Scenario
9.2.2.5 Regulatory Framework
9.2.2.6 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Canada Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2 Uk
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 Uk Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Germany Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 France Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Spain
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Spain Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Italy
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Italy Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Denmark Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.7.4 Competitive Scenario
9.3.7.5 Regulatory Framework
9.3.7.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Target Disease Prevalence
9.3.8.3 Sweden Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Target Disease Prevalence
9.3.9.3 Norway Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.10 Rest Of Europe
9.4 Asia Pacific
9.4.1 Asia Pacific Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Death Rate In Japan
9.4.2.3 Target Disease Prevalence
9.4.2.4 Japan Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2.5 Competitive Scenario
9.4.2.6 Regulatory Framework
9.4.2.7 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 China Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 India Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4.4 Competitive Scenario’
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 South Korea
9.4.5.1 Key Country Dynamics
9.4.5.2 Target Disease Prevalence
9.4.5.3 South Korea Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 Australia
9.4.6.1 Key Country Dynamics
9.4.6.2 Target Disease Prevalence
9.4.6.3 Australia Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Target Disease Prevalence
9.4.7.3 Thailand Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.7.4 Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.4.8 Rest Of Asia Pacific
9.5 Latin America
9.5.1 Latin America Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Mexico Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Argentina Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.5 Rest Of Latin America
9.6 MEA
9.6.1 MEA Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 Target Disease Prevalence
9.6.2.3 South Africa Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Target Disease Prevalence
9.6.3.3 Saudi Arabia Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 Target Disease Prevalence
9.6.4.3 Uae Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Target Disease Prevalence
9.6.5.3 Kuwait Thrombosis & Hemostasis Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
9.6.6 Rest Of Mea
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 Thermo Fisher Scientific, Inc.
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 F. Hoffmann-La Roche Ltd.
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 Siemens Healthineers
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Abbott
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 BioMérieux SA
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiative
10.4.6 Werfen
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 HORIBA Ltd.
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 Quidel Corporation
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Diazyme Laboratories, Inc.
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 Biomedica Diagnostics
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 Thermo Fisher Scientific, Inc.
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 F. Hoffmann-La Roche Ltd.
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 Siemens Healthineers
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Abbott
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 BioMérieux SA
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiative
10.4.6 Werfen
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 HORIBA Ltd.
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 Quidel Corporation
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Diazyme Laboratories, Inc.
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 Biomedica Diagnostics
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviations
Table 3: Global thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 4: Global thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 5: Global thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 6: Global thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 7: Global thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 8: Global thrombosis & hemostasis biomarkers market, by region, 2018-2030 (USD Million)
Table 9: North America thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 10: North America thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 11: North America thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 12: North America thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 13: North America thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 14: North America thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 15: U.S. thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 16: U.S. thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 17: U.S. thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 18: U.S. thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 19: U.S. thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 20: Canada thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 21: Canada thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 22: Canada thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 23: Canada thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 24: Canada thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 25: Europe thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 26: Europe thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 27: Europe thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 28: Europe thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 29: Europe thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 30: Europe thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 31: Germany thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 32: Germany thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 33: Germany thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 34: Germany thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 35: Germany thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 36: UK thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 37: UK thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 38: UK thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 39: UK thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 40: UK thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 41: France thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 42: France thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 43: France thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 44: France thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 45: France thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 46: Italy thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 47: Italy thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 48: Italy thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 49: Italy thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 50: Italy thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 51: Spain thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 52: Spain thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 53: Spain thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 54: Spain thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 55: Spain thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 56: Denmark thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 57: Denmark thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 58: Denmark thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 59: Denmark thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 60: Denmark thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 61: Sweden thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 62: Sweden thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 63: Sweden thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 64: Sweden thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 65: Sweden thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 66: Norway thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 67: Norway thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 68: Norway thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 69: Norway thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 70: Norway thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 71: Asia Pacific thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 72: Asia Pacific thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 73: Asia Pacific thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 74: Asia Pacific thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 75: Asia Pacific thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 76: Asia Pacific thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 77: China thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 78: China thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 79: China thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 80: China thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 81: China thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 82: Japan thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 83: Japan thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 84: Japan thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 85: Japan thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 86: Japan thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 87: India thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 88: India thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 89: India thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 90: India thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 91: India thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 92: South Korea thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 93: South Korea thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 94: South Korea thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 95: South Korea thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 96: South Korea thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 97: Australia thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 98: Australia thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 99: Australia thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 100: Australia thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 101: Australia thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 102: Thailand thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 103: Thailand thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 104: Thailand thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 105: Thailand thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 106: Thailand thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 107: Latin America thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 108: Latin America thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 109: Latin America thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 110: Latin America thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 111: Latin America thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 112: Latin America thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 113: Brazil thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 114: Brazil thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 115: Brazil thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 116: Brazil thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 117: Brazil thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 118: Mexico thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 119: Mexico thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 120: Mexico thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 121: Mexico thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 122: Mexico thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 123: Argentina thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 124: Argentina thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 125: Argentina thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 126: Argentina thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 127: Argentina thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 128: Middle East & Africa thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 129: Middle East & Africa thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 130: Middle East & Africa thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 131: Middle East & Africa thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 132: Middle East & Africa thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 133: South Africa thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 134: South Africa thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 135: South Africa thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 136: South Africa thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 137: South Africa thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 138: Saudi Arabia thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 139: Saudi Arabia thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 140: Saudi Arabia thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 141: Saudi Arabia thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 142: Saudi Arabia thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 143: UAE thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 144: UAE thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 145: UAE thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 146: UAE thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 147: UAE thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 148: Kuwait thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 149: Kuwait thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 150: Kuwait thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 151: Kuwait thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 152: Kuwait thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 2: List of Abbreviations
Table 3: Global thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 4: Global thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 5: Global thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 6: Global thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 7: Global thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 8: Global thrombosis & hemostasis biomarkers market, by region, 2018-2030 (USD Million)
Table 9: North America thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 10: North America thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 11: North America thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 12: North America thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 13: North America thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 14: North America thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 15: U.S. thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 16: U.S. thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 17: U.S. thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 18: U.S. thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 19: U.S. thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 20: Canada thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 21: Canada thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 22: Canada thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 23: Canada thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 24: Canada thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 25: Europe thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 26: Europe thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 27: Europe thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 28: Europe thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 29: Europe thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 30: Europe thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 31: Germany thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 32: Germany thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 33: Germany thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 34: Germany thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 35: Germany thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 36: UK thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 37: UK thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 38: UK thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 39: UK thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 40: UK thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 41: France thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 42: France thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 43: France thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 44: France thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 45: France thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 46: Italy thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 47: Italy thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 48: Italy thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 49: Italy thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 50: Italy thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 51: Spain thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 52: Spain thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 53: Spain thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 54: Spain thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 55: Spain thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 56: Denmark thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 57: Denmark thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 58: Denmark thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 59: Denmark thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 60: Denmark thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 61: Sweden thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 62: Sweden thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 63: Sweden thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 64: Sweden thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 65: Sweden thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 66: Norway thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 67: Norway thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 68: Norway thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 69: Norway thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 70: Norway thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 71: Asia Pacific thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 72: Asia Pacific thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 73: Asia Pacific thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 74: Asia Pacific thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 75: Asia Pacific thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 76: Asia Pacific thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 77: China thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 78: China thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 79: China thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 80: China thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 81: China thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 82: Japan thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 83: Japan thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 84: Japan thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 85: Japan thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 86: Japan thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 87: India thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 88: India thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 89: India thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 90: India thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 91: India thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 92: South Korea thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 93: South Korea thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 94: South Korea thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 95: South Korea thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 96: South Korea thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 97: Australia thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 98: Australia thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 99: Australia thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 100: Australia thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 101: Australia thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 102: Thailand thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 103: Thailand thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 104: Thailand thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 105: Thailand thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 106: Thailand thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 107: Latin America thrombosis & hemostasis biomarkers market, by country, 2018-2030 (USD Million)
Table 108: Latin America thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 109: Latin America thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 110: Latin America thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 111: Latin America thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 112: Latin America thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 113: Brazil thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 114: Brazil thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 115: Brazil thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 116: Brazil thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 117: Brazil thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 118: Mexico thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 119: Mexico thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 120: Mexico thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 121: Mexico thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 122: Mexico thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 123: Argentina thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 124: Argentina thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 125: Argentina thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 126: Argentina thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 127: Argentina thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 128: Middle East & Africa thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 129: Middle East & Africa thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 130: Middle East & Africa thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 131: Middle East & Africa thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 132: Middle East & Africa thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 133: South Africa thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 134: South Africa thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 135: South Africa thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 136: South Africa thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 137: South Africa thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 138: Saudi Arabia thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 139: Saudi Arabia thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 140: Saudi Arabia thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 141: Saudi Arabia thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 142: Saudi Arabia thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 143: UAE thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 144: UAE thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 145: UAE thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 146: UAE thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 147: UAE thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
Table 148: Kuwait thrombosis & hemostasis biomarkers market, by product, 2018-2030 (USD Million)
Table 149: Kuwait thrombosis & hemostasis biomarkers market, by test location, 2018-2030 (USD Million)
Table 150: Kuwait thrombosis & hemostasis biomarkers market, by test type, 2018-2030 (USD Million)
Table 151: Kuwait thrombosis & hemostasis biomarkers market, by applications, 2018-2030 (USD Million)
Table 152: Kuwait thrombosis & hemostasis biomarkers market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Thrombosis & hemostasis biomarkers market segmentation
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market snapshot
Fig. 10: Product and test location segment snapshot
Fig. 11: Test type segment snapshot
Fig. 12: Application and end-use segment snapshot
Fig. 13: Competitive landscape snapshot
Fig. 14: IVD market value, 2022 (USD Million)
Fig. 15: Market dynamics
Fig. 16: Incidence of global pancreatic cancer, 2017-2021
Fig. 17: Porter’s five forces analysis
Fig. 18: PESTLE analysis
Fig. 19: Thrombosis & hemostasis biomarkers market: Product outlook and key takeaways
Fig. 20: Thrombosis & hemostasis biomarkers market: Product movement analysis
Fig. 21: Analyzers Market Estimates and Forecast, 2018-2030 (USD Million)
Fig. 22: Reagents & consumables market estimates and forecast, 2018-2030 (USD Million)
Fig. 23: Thrombosis & hemostasis biomarkers market: Test location outlook and key takeaways
Fig. 24: Thrombosis & hemostasis biomarkers market: Test location movement analysis
Fig. 25: Clinical laboratory tests market estimates and forecast, 2018-2030 (USD Million)
Fig. 26: Point-of-care tests market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Thrombosis & hemostasis biomarkers market: Test type outlook and key takeaways
Fig. 28: Thrombosis & hemostasis biomarkers market: Test type movement analysis
Fig. 29: D- dimer test market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: Anti-thrombin III market estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Plasminogen market estimates and forecast, 2018-2030 (USD Million)
Fig. 32: Fibrin/Fibrinogen Market Estimates and Forecast, 2018-2030, USD Million
Fig. 33: Soluble fibrin market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Selectins Market Estimates and Forecast, 2018-2030, USD Million
Fig. 35: Factor VIII market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: PT market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: APTT Market Estimates and Forecast, 2018-2030, USD Million
Fig. 38: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Thrombosis & hemostasis biomarkers market: Application outlook and key takeaways
Fig. 40: Thrombosis & hemostasis biomarkers market: Application movement analysis
Fig. 41: Deep Vein Thrombosis (DVT) market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: Pulmonary Embolism (PE) market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Disseminated Intravascular Coagulation (DIC) market estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Thrombosis & hemostasis biomarkers market: End-use outlook and key takeaways
Fig. 46: Thrombosis & hemostasis biomarkers market: End-use movement analysis
Fig. 47: Hospitals & clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Academic & research institute market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Diagnostic centers market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Thrombosis & hemostasis biomarkers market revenue, by region, 2022 & 2030, (USD Million)
Fig. 52: Regional marketplace: Key takeaways
Fig. 53: Regional marketplace: Key takeaways
Fig. 54: North America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55: Key country dynamics
Fig. 56: U.S. thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57: Key country dynamics
Fig. 58: Canada thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59: Europe thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60: Key country dynamics
Fig. 61: UK thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62: Key country dynamics
Fig. 63: Germany thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64: Key country dynamics
Fig. 65: France thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66: Key country dynamics
Fig. 67: Spain thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68: Key country dynamics
Fig. 69: Italy thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70: Key country dynamics
Fig. 71: Denmark thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72: Key country dynamics
Fig. 73: Sweden thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74: Key country dynamics
Fig. 75: Norway thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76: Rest of Europe thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD, Million)
Fig. 77: Asia Pacific thrombosis & hemostasis biomarkers market estimates and forecast, 2018-2030, (USD Million)
Fig. 78: Key country dynamics
Fig. 79: Japan thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 80: Key country dynamics
Fig. 81: China thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 82: Key country dynamics
Fig. 83: India thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 84: Key country dynamics
Fig. 85: South Korea thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 86: South Korea reimbursement scenario
Fig. 87: Key country dynamics
Fig. 88: Australia thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 89: Key country dynamics
Fig. 90: Thailand thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 91: Rest of Asia Pacific thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 92: Latin America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 93: Key country dynamics
Fig. 94: Brazil thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 95: Key country dynamics
Fig. 96: Mexico thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 97: Key country dynamics
Fig. 98: Argentina thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 99: Rest of Latin America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 100: MEA thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 101: Key country dynamics
Fig. 102: South Africa thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 103: Key country dynamics
Fig. 104: Saudi Arabia thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 105: Key country dynamics
Fig. 106: UAE thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 107: Key country dynamics
Fig. 108: Kuwait thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 109: Rest of MEA thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 110: Key company categorization
Fig. 111: Company categorization
Fig. 112: Company market share analysis, 2022
Fig. 113: North America - company market share analysis, 2022
Fig. 114: Europe- company market share analysis, 2022
Fig. 115: Asia Pacific- company market share analysis, 2022
Fig. 116: Latin America- company market share analysis, 2022
Fig. 117: MEA- company market share analysis, 2022
Fig. 118: Strategic framework
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market snapshot
Fig. 10: Product and test location segment snapshot
Fig. 11: Test type segment snapshot
Fig. 12: Application and end-use segment snapshot
Fig. 13: Competitive landscape snapshot
Fig. 14: IVD market value, 2022 (USD Million)
Fig. 15: Market dynamics
Fig. 16: Incidence of global pancreatic cancer, 2017-2021
Fig. 17: Porter’s five forces analysis
Fig. 18: PESTLE analysis
Fig. 19: Thrombosis & hemostasis biomarkers market: Product outlook and key takeaways
Fig. 20: Thrombosis & hemostasis biomarkers market: Product movement analysis
Fig. 21: Analyzers Market Estimates and Forecast, 2018-2030 (USD Million)
Fig. 22: Reagents & consumables market estimates and forecast, 2018-2030 (USD Million)
Fig. 23: Thrombosis & hemostasis biomarkers market: Test location outlook and key takeaways
Fig. 24: Thrombosis & hemostasis biomarkers market: Test location movement analysis
Fig. 25: Clinical laboratory tests market estimates and forecast, 2018-2030 (USD Million)
Fig. 26: Point-of-care tests market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Thrombosis & hemostasis biomarkers market: Test type outlook and key takeaways
Fig. 28: Thrombosis & hemostasis biomarkers market: Test type movement analysis
Fig. 29: D- dimer test market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: Anti-thrombin III market estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Plasminogen market estimates and forecast, 2018-2030 (USD Million)
Fig. 32: Fibrin/Fibrinogen Market Estimates and Forecast, 2018-2030, USD Million
Fig. 33: Soluble fibrin market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Selectins Market Estimates and Forecast, 2018-2030, USD Million
Fig. 35: Factor VIII market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: PT market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: APTT Market Estimates and Forecast, 2018-2030, USD Million
Fig. 38: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Thrombosis & hemostasis biomarkers market: Application outlook and key takeaways
Fig. 40: Thrombosis & hemostasis biomarkers market: Application movement analysis
Fig. 41: Deep Vein Thrombosis (DVT) market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: Pulmonary Embolism (PE) market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Disseminated Intravascular Coagulation (DIC) market estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Thrombosis & hemostasis biomarkers market: End-use outlook and key takeaways
Fig. 46: Thrombosis & hemostasis biomarkers market: End-use movement analysis
Fig. 47: Hospitals & clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Academic & research institute market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Diagnostic centers market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Thrombosis & hemostasis biomarkers market revenue, by region, 2022 & 2030, (USD Million)
Fig. 52: Regional marketplace: Key takeaways
Fig. 53: Regional marketplace: Key takeaways
Fig. 54: North America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55: Key country dynamics
Fig. 56: U.S. thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57: Key country dynamics
Fig. 58: Canada thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59: Europe thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60: Key country dynamics
Fig. 61: UK thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62: Key country dynamics
Fig. 63: Germany thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64: Key country dynamics
Fig. 65: France thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66: Key country dynamics
Fig. 67: Spain thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68: Key country dynamics
Fig. 69: Italy thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70: Key country dynamics
Fig. 71: Denmark thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72: Key country dynamics
Fig. 73: Sweden thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74: Key country dynamics
Fig. 75: Norway thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76: Rest of Europe thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD, Million)
Fig. 77: Asia Pacific thrombosis & hemostasis biomarkers market estimates and forecast, 2018-2030, (USD Million)
Fig. 78: Key country dynamics
Fig. 79: Japan thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 80: Key country dynamics
Fig. 81: China thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 82: Key country dynamics
Fig. 83: India thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 84: Key country dynamics
Fig. 85: South Korea thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 86: South Korea reimbursement scenario
Fig. 87: Key country dynamics
Fig. 88: Australia thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 89: Key country dynamics
Fig. 90: Thailand thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 91: Rest of Asia Pacific thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 92: Latin America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 93: Key country dynamics
Fig. 94: Brazil thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 95: Key country dynamics
Fig. 96: Mexico thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 97: Key country dynamics
Fig. 98: Argentina thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 99: Rest of Latin America thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 100: MEA thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 101: Key country dynamics
Fig. 102: South Africa thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 103: Key country dynamics
Fig. 104: Saudi Arabia thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 105: Key country dynamics
Fig. 106: UAE thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 107: Key country dynamics
Fig. 108: Kuwait thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 109: Rest of MEA thrombosis & hemostasis biomarkers market estimates and forecasts, 2018-2030 (USD Million)
Fig. 110: Key company categorization
Fig. 111: Company categorization
Fig. 112: Company market share analysis, 2022
Fig. 113: North America - company market share analysis, 2022
Fig. 114: Europe- company market share analysis, 2022
Fig. 115: Asia Pacific- company market share analysis, 2022
Fig. 116: Latin America- company market share analysis, 2022
Fig. 117: MEA- company market share analysis, 2022
Fig. 118: Strategic framework
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Abbott
- BioMérieux SA
- Werfen
- HORIBA Ltd.
- Quidel Corporation
- Diazyme Laboratories, Inc.
- Biomedica Diagnostics
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | June 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5.01 Billion |
| Forecasted Market Value ( USD | $ 7.92 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
